Ads
related to: age-related macular degeneration treatment
Search results
Age-Related Macular Degeneration: Putting a Hole in Our World
WebMD· 2 days agoWhen we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to our world – the macula ...
Disease latency bias and the protective effect of metformin against age-related macular degeneration...
Nature· 23 hours agoThere arises a spurious association between the older medication and absence of the condition causing symptoms. Metformin is an old medication, but it remains the first-line treatment ...
The American Macular Degeneration Foundation Showc | Newswise
Newswise· 3 days ago“Our goal is to advance the development of treatments, tools and usable information that improve the lives of those affected by AMD and, just as important, a sense of hope ...
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and...
KOLR - KSFX Ozarks· 3 days agoAge-related macular degeneration (AMD) is a leading cause of severe vision loss for people aged 50 years and older ...
Earnings call: Lineage Cell Therapeutics reports positive OpRegen trial results By Investing.com
Investing.com· 1 day agoIn a recent earnings call, Lineage Cell Therapeutics (NYSE:LCTX), a biotechnology company...
EyePoint tumbles 30% premarket on failed Phase 2 study (NASDAQ:EYPT)
Seeking Alpha· 6 days agoEyePoint (EYPT) stock tumbled nearly 30% in premarket trading Monday after the company said a Phase...
EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Estimates Despite Challenges
GuruFocus.com via Yahoo Finance· 1 day agoThe company utilizes its proprietary Durasert E and Verisome technology platforms to develop ...
Telomir Pharmaceuticals sees breakthrough potential in Anti-Aging Treatment with Telomir 1
Proactive Investors· 5 days agoDuring a recent interview, O'Donnell elaborated on the drug’s potential, supported by extensive...
Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Projections Amidst Revenue Declines
GuruFocus.com via Yahoo Finance· 1 day agoThe company also reported positive long-term data from its OpRegen treatment, showing sustained visual benefits, which underscores the therapys potential in treating geographic ...
EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Market Watch· 6 days agodropped nearly 30% in premarket trading Monday after the company said its experimental...
